| Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
|---|---|---|---|---|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | 1472 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | 1517 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | 1548 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | 1623 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | 1631 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | 2193 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | 2459 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | 2587 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | 3693 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | 4637 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | 5307 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | 9105 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | 16472 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Case | N | Exemestane | Black | Baseline | N | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Case | N | Exemestane | White | Baseline | N | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Case | N | Letrozole | White | 3 Month | N | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Case | N | Letrozole | White | Baseline | N | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Case | Y | Exemestane | White | Baseline | N | Y | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Case | Y | Exemestane | White | Baseline | Y | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | N | Exemestane | Black | Baseline | Y | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | N | Exemestane | White | 3 Month | Y | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | N | Exemestane | White | Baseline | Y | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | N | Letrozole | Black | Baseline | N | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | N | Letrozole | White | 3 Month | N | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | Y | Exemestane | White | 3 Month | N | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | Y | Exemestane | White | Baseline | N | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | Y | Letrozole | White | Baseline | Y | N | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)- | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|